Carmela Pratelli
YOU?
Author Swipe
View article: Supplementary Figure 2 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 2 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 32K, Effects of different compound AXIN stabilizers on TNKS1 and TNKS2.
View article: Supplementary Figure 6 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 6 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 112K, Average body weight graph.
View article: Supplementary Figure Legend from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure Legend from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 81K
View article: Data from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Data from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
Glioblastoma multiforme (GBM) is the most common and prognostically unfavorable form of brain tumor. The aggressive and highly invasive phenotype of these tumors makes them among the most anatomically damaging human cancers with a median s…
View article: Supplementary Figure Legend from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure Legend from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 81K
View article: Supplementary Figure 1 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 1 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 94K, Consequences of inhibition of WNT signaling in glioblastoma cells: a less proliferative and less tumorigenic phenotype.
View article: Supplementary Figure 4 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 4 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 10K, SEN461 affects canonical WNT ligands mediated transcription.
View article: Supplementary Figure 2 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 2 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 32K, Effects of different compound AXIN stabilizers on TNKS1 and TNKS2.
View article: Supplementary Figure 3 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 3 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 20K, Comparative WNT transcriptional activity and growth inhibition with different compound AXIN stabilizers.
View article: Supplementary Figure 5 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 5 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 98K, In vitro response of T98G cells to WNT signaling inhibition.
View article: Data from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Data from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
Glioblastoma multiforme (GBM) is the most common and prognostically unfavorable form of brain tumor. The aggressive and highly invasive phenotype of these tumors makes them among the most anatomically damaging human cancers with a median s…
View article: Supplementary Figure 1 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 1 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 94K, Consequences of inhibition of WNT signaling in glioblastoma cells: a less proliferative and less tumorigenic phenotype.
View article: Supplementary Figure 4 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 4 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 10K, SEN461 affects canonical WNT ligands mediated transcription.
View article: Supplementary Figure 3 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 3 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 20K, Comparative WNT transcriptional activity and growth inhibition with different compound AXIN stabilizers.
View article: Supplementary Figure 6 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 6 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 112K, Average body weight graph.
View article: Supplementary Figure 5 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Supplementary Figure 5 from Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells Open
PDF file - 98K, In vitro response of T98G cells to WNT signaling inhibition.
View article: Structure–activity relationship and properties optimization of a series of Quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway
Structure–activity relationship and properties optimization of a series of Quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway Open